The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex

The New England Journal of Medicine
Mathuram SantoshamW Newcomer

Abstract

Several conjugate vaccines against Haemophilus influenzae type b have been developed in the search for one that induces protection even in young infants. We evaluated the safety and efficacy of a conjugate vaccine that links the H. influenzae type b capsular polysaccharide to the outer-membrane protein complex (OMPC) of Neisseria meningitidis serogroup B. We conducted a double-blind, placebo, controlled trial in Navajo infants, who are at high risk for systemic infections caused by H. influenzae type b. The infants were randomly assigned to receive the first dose of vaccine or placebo at 42 to 90 days of age and the second at 70 to 146 days of age. Of the infants in the trial, 2588 were assigned to receive the vaccine and 2602 to receive placebo. The mean follow-up was 269 days in the vaccine group and 267 days in the placebo group. Before the age of 18 months, there was 1 systemic H. influenzae type b infection in the vaccine group, as compared with 22 in the placebo group (P less than 0.001; point estimate of efficacy, 95 percent; 95 percent confidence interval, 72 to 99 percent). Of the 22 H. influenzae type b infections in the placebo group, 13 were meningitis. Among the children who received both doses, there was 1 H. infl...Continue Reading

References

May 1, 1975·American Journal of Diseases of Children·J K Todd, F W Bruhn
Aug 1, 1987·The Pediatric Infectious Disease Journal·C V Broome
Mar 22, 1985·JAMA : the Journal of the American Medical Association·W F SchlechC V Broome

❮ Previous
Next ❯

Citations

Aug 10, 2006·JAMA : the Journal of the American Medical Association·Karen D CowgillJ Anthony G Scott
Feb 24, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C O Obonyo, J Lau
Jul 10, 2007·Current Infectious Disease Reports·Mark Alain Dery, Rodrigo Hasbun
Jun 24, 2009·Current Infectious Disease Reports·Renuka Verma, Margaret C Fisher
Oct 1, 1994·Controlled Clinical Trials·D A BerryD Sack
Mar 23, 2004·Journal of the American Academy of Dermatology·Jashin J WuStephen K Tyring
Aug 10, 2000·Vaccine·A D HorneK L Goldenthal
Aug 3, 2001·Vaccine·J R LingappaUNKNOWN Active Bacterial Core surveillance (ABCs) team
Apr 23, 2003·Vaccine·Lucia H LeeCarolyn D Deal
Sep 2, 1999·Infectious Disease Clinics of North America·H Peltola
Jan 1, 1994·International Journal of Technology Assessment in Health Care·K E Stein
May 19, 1998·Nature Medicine·M R Hilleman
Nov 3, 2006·Nature Reviews. Drug Discovery·Jacqueline L Deen, John D Clemens
Dec 17, 1992·The New England Journal of Medicine·G Peter
Jun 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K Mulholland
Nov 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M Granoff
Dec 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L K BallT M Finn
Mar 1, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eugene V MillarMathuram Santosham
May 20, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·G S Giebink
Jul 1, 1997·The Pediatric Infectious Disease Journal·S T SigurdardottirI Jonsdottir
Oct 22, 1998·The Pediatric Infectious Disease Journal·P T Heath
Oct 22, 1998·The Pediatric Infectious Disease Journal·H Peltola
Dec 23, 1999·The Pediatric Infectious Disease Journal·O S LevineM M Levine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.